Ticker: SKBI, Company: SKYSTAR BIO-PHARMACEUTICAL CO, Type: 8-K, Date: 2010-11-16
Original SEC Filing: Click here

---

Webplus: SKBI/20101116/8-K_1/2_EX-99.1/000.htm SEC Original: v202888_ex99-1.htm
NEWS RELEASE Skystar Bio-Pharmaceutical Announces Record Organic Revenues of $18.5 Million For Third Quarter Fiscal Year 2010 – Company reiterates fiscal 2010 guidance of $45.5 Million to $47.5 Million – XI’AN, CHINA – November 16, 2010 — – Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) (“Skystar” or the “Company”), Third Quarter 2010 Highlights · Revenue increases 45% YoY to record $18.5 million ·

---

---

Webplus: SKBI/20101116/8-K_1/1/000.htm SEC Original: v202888_8k.htm
FORM 8-K CURRENT REPORT Date of report (Date of earliest event reported): November 16, 2010 (November 16, 2010) SKYSTAR BIO-PHARMACEUTICAL COMPANY Nevada 001-34394 33-0901534 (State or other jurisdiction of incorporation or organization) (Commission File No.) (IRS Employer Identification No.) Rm. 10601, Jiezuo Plaza, No.4, Fenghui Road South, Gaoxin District, Xi’an, Shaanxi Province, P.R. China (8629) 8819-3188 (Issuer Telephone Number) N/A

---

Company Information:

Ticker: SKBI, Company: SKYSTAR BIO-PHARMACEUTICAL CO, Type: 8-K, Date: 2010-11-16CIK: 0001076939, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
RM 10601, JIEZUO PLAZA, NO. 4, FENGHUI ROAD SOUTH, GAOXIN DISTRICT
XIAN PROVINCE